Comparative gastric ulcerogenic effects of meseclazone, 5-chlorosalicylic acid and other nonsteroidal anti-inflammatory drugs following acute and repeated oral administration to rats.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000633:toxicity*; D048588:Benzoxazines; D001711:Biotransformation; D005279:Fenoprofen / Q000633:toxicity; D007052:Ibuprofen / Q000633:toxicity; D007213:Indomethacin / Q000633:toxicity; D008297:Male; D009288:Naproxen / Q000633:toxicity; D010078:Oxazines / Q000031:analogs & derivatives / Q000378:metabolism / Q000633:toxicity*; D010438:Peptic Ulcer Hemorrhage / Q000139:chemically induced; D010653:Phenylbutazone / Q000633:toxicity; D051381:Rats; D012459:Salicylates / Q000633:toxicity; D013276:Stomach Ulcer / Q000139:chemically induced*; D013997:Time Factors; D014046:Tolmetin / Q000633:toxicity
D000893:Anti-Inflammatory Agents; D048588:Benzoxazines; D010078:Oxazines; D012459:Salicylates; C006165:meseclazone; D009288:Naproxen; D014046:Tolmetin; D010653:Phenylbutazone; C015751:5-chlorosalicylic acid; D005279:Fenoprofen; D007052:Ibuprofen; D007213:Indomethacin